ISRG
Same love, less enthusiasm
Baird is still waving the bull flag on Intuitive Surgical, but the firm dialed down its price target to $575 from $645. That’s not a breakup. It’s more like changing your phone wallpaper from a beach vacation to a slightly less glamorous beach vacation.
Why investors care
When a big-name analyst cuts the target but keeps the positive rating, the market usually hears two things at once:
- the long-term story is still intact
- but near-term expectations may have gotten a little too spicy
For ISRG, that matters because the stock has already been under pressure, with shares down about 17.5% this year even after a recent bounce. So this update doesn’t scream disaster — but it does suggest the easy upside might be less easy than it looked a few months ago.
The broader analyst drumbeat
Baird’s move also comes amid a flurry of target cuts across the Street, including Truist, Mizuho, BTIG, and Evercore ISI. In other words, this isn’t a one-off mood swing; it looks more like a group therapy session for analysts recalibrating their expectations.
Big picture: ISRG still has believers, but the bulls are getting a little less aggressive. That’s not exactly the stuff of moon-shot headlines, but it can still shape how much multiple investors are willing to pay for the company’s next chapter.